Verastem Inc (VSTM)
10.90
+0.54
(+5.21%)
USD |
NASDAQ |
May 03, 16:00
10.57
-0.33
(-3.03%)
After-Hours: 20:00
Verastem Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | 2.596M |
| December 31, 2021 | 0.545M |
| September 30, 2021 | 0.002M |
| June 30, 2021 | 0.50M |
| March 31, 2021 | 1.006M |
| December 31, 2020 | 0.506M |
| September 30, 2020 | 78.65M |
| June 30, 2020 | 4.307M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.056M |
| December 31, 2019 | 3.616M |
| September 30, 2019 | 9.032M |
| June 30, 2019 | 3.136M |
| March 31, 2019 | 1.671M |
| December 31, 2018 | 1.21M |
| September 30, 2018 | 15.51M |
| June 30, 2018 | 10.00M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.002M
Minimum
Sep 2021
78.65M
Maximum
Sep 2020
9.079M
Average
2.866M
Median
Revenue (Quarterly) Benchmarks
| Johnson & Johnson | 21.38B |
| Geron Corp | 0.304M |
| Altimmune Inc | 0.037M |
| Oragenics Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.37M |
| Total Expenses (Quarterly) | 31.14M |
| EPS Diluted (Quarterly) | -1.03 |
| Enterprise Value | 178.81M |
| Earnings Yield | -37.71% |
| Normalized Earnings Yield | -45.14 |